
### [MONDO:0005495](http://purl.obolibrary.org/obo/MONDO_0005495)
**Label:** adrenal gland disease

**Subclasses:** [MONDO:0014200](http://purl.obolibrary.org/obo/MONDO_0014200) (aldosterone-producing adenoma with seizures and neurological abnormalities), [MONDO:0020527](http://purl.obolibrary.org/obo/MONDO_0020527) (ectopic Cushing syndrome), [MONDO:0020528](http://purl.obolibrary.org/obo/MONDO_0020528) (ACTH-dependent Cushing syndrome), [MONDO:0020529](http://purl.obolibrary.org/obo/MONDO_0020529) (ACTH-independent Cushing syndrome), [MONDO:0010264](http://purl.obolibrary.org/obo/MONDO_0010264) (X-linked adrenal hypoplasia congenita), [MONDO:0018300](http://purl.obolibrary.org/obo/MONDO_0018300) (genetic hyperaldosteronism), [MONDO:0009410](http://purl.obolibrary.org/obo/MONDO_0009410) (Addison's disease), [MONDO:0007903](http://purl.obolibrary.org/obo/MONDO_0007903) (Li-Fraumeni syndrome 1), [MONDO:0012509](http://purl.obolibrary.org/obo/MONDO_0012509) (pigmented nodular adrenocortical disease, primary, 1), [MONDO:0006015](http://purl.obolibrary.org/obo/MONDO_0006015) (Waterhouse-Friderichsen syndrome), [MONDO:0007540](http://purl.obolibrary.org/obo/MONDO_0007540) (multiple endocrine neoplasia type 1), [MONDO:0011576](http://purl.obolibrary.org/obo/MONDO_0011576) (familial hyperaldosteronism type II), [MONDO:0013616](http://purl.obolibrary.org/obo/MONDO_0013616) (pigmented nodular adrenocortical disease, primary, 3), [MONDO:0016525](http://purl.obolibrary.org/obo/MONDO_0016525) (familial hyperaldosteronism), [MONDO:0012505](http://purl.obolibrary.org/obo/MONDO_0012505) (pigmented nodular adrenocortical disease, primary, 2), [MONDO:0013359](http://purl.obolibrary.org/obo/MONDO_0013359) (familial hyperaldosteronism type III), [MONDO:0015999](http://purl.obolibrary.org/obo/MONDO_0015999) (primary pigmented nodular adrenocortical disease), [MONDO:0018627](http://purl.obolibrary.org/obo/MONDO_0018627) (ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor), [MONDO:0017820](http://purl.obolibrary.org/obo/MONDO_0017820) (disease with Cushing syndrome as a major feature), [MONDO:0007080](http://purl.obolibrary.org/obo/MONDO_0007080) (glucocorticoid-remediable aldosteronism), [MONDO:0018875](http://purl.obolibrary.org/obo/MONDO_0018875) (Li-Fraumeni syndrome), [MONDO:0013400](http://purl.obolibrary.org/obo/MONDO_0013400) (congenital adrenal insufficiency), [MONDO:0012234](http://purl.obolibrary.org/obo/MONDO_0012234) (LFS3), [MONDO:0015285](http://purl.obolibrary.org/obo/MONDO_0015285) (Carney complex), [MONDO:0012233](http://purl.obolibrary.org/obo/MONDO_0012233) (Li-Fraumeni syndrome 2), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0009025](http://purl.obolibrary.org/obo/MONDO_0009025) (apparent mineralocorticoid excess), [MONDO:0008211](http://purl.obolibrary.org/obo/MONDO_0008211) (pseudoleprechaunism syndrome, Patterson type), [MONDO:0008057](http://purl.obolibrary.org/obo/MONDO_0008057) (Carney complex, type 1), [MONDO:0009049](http://purl.obolibrary.org/obo/MONDO_0009049) (Cushing syndrome due to macronodular adrenal hyperplasia), [MONDO:0015460](http://purl.obolibrary.org/obo/MONDO_0015460) (adrenocortical carcinoma), [MONDO:0008732](http://purl.obolibrary.org/obo/MONDO_0008732) (adrenal hypoplasia, Cytomegalic type), [MONDO:0008734](http://purl.obolibrary.org/obo/MONDO_0008734) (adrenocortical carcinoma, hereditary), [MONDO:0018919](http://purl.obolibrary.org/obo/MONDO_0018919) (McCune-Albright syndrome), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0012675](http://purl.obolibrary.org/obo/MONDO_0012675) (corticosteroid-binding globulin deficiency), [MONDO:0014359](http://purl.obolibrary.org/obo/MONDO_0014359) (pigmented nodular adrenocortical disease, primary, 4), [MONDO:0011525](http://purl.obolibrary.org/obo/MONDO_0011525) (CNC2), [MONDO:0018912](http://purl.obolibrary.org/obo/MONDO_0018912) (Cushing syndrome), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0007071](http://purl.obolibrary.org/obo/MONDO_0007071) (adrenocortical hypofunction, chronic primary congenital), [MONDO:0014416](http://purl.obolibrary.org/obo/MONDO_0014416) (Acth-Independent macronodular adrenal hyperplasia 2), 

**Corr. equiv. classes:** [Orphanet:562](http://www.orpha.net/ORDO/Orphanet_562), [Orphanet:320](http://www.orpha.net/ORDO/Orphanet_320), [OMIM:605635](http://purl.obolibrary.org/obo/OMIM_605635), [Orphanet:199244](http://www.orpha.net/ORDO/Orphanet_199244), [OMIM:300200](http://purl.obolibrary.org/obo/OMIM_300200), [OMIM:614190](http://purl.obolibrary.org/obo/OMIM_614190), [Orphanet:369929](http://www.orpha.net/ORDO/Orphanet_369929), [Orphanet:199247](http://www.orpha.net/ORDO/Orphanet_199247), [Orphanet:95702](http://www.orpha.net/ORDO/Orphanet_95702), [OMIM:219090](http://purl.obolibrary.org/obo/OMIM_219090), [OMIM:610475](http://purl.obolibrary.org/obo/OMIM_610475), [OMIM:611489](http://purl.obolibrary.org/obo/OMIM_611489), [OMIM:103900](http://purl.obolibrary.org/obo/OMIM_103900), [OMIM:613743](http://purl.obolibrary.org/obo/OMIM_613743), [Orphanet:319340](http://www.orpha.net/ORDO/Orphanet_319340), [Orphanet:251274](http://www.orpha.net/ORDO/Orphanet_251274), [Orphanet:100067](http://www.orpha.net/ORDO/Orphanet_100067), [Orphanet:553](http://www.orpha.net/ORDO/Orphanet_553), [OMIM:202300](http://purl.obolibrary.org/obo/OMIM_202300), [Orphanet:85138](http://www.orpha.net/ORDO/Orphanet_85138), [OMIM:131100](http://purl.obolibrary.org/obo/OMIM_131100), [Orphanet:2976](http://www.orpha.net/ORDO/Orphanet_2976), [Orphanet:189439](http://www.orpha.net/ORDO/Orphanet_189439), [Orphanet:168558](http://www.orpha.net/ORDO/Orphanet_168558), [OMIM:219080](http://purl.obolibrary.org/obo/OMIM_219080), [OMIM:613677](http://purl.obolibrary.org/obo/OMIM_613677), [OMIM:610489](http://purl.obolibrary.org/obo/OMIM_610489), [Orphanet:371861](http://www.orpha.net/ORDO/Orphanet_371861), [OMIM:218030](http://purl.obolibrary.org/obo/OMIM_218030), [OMIM:609265](http://purl.obolibrary.org/obo/OMIM_609265), [OMIM:609266](http://purl.obolibrary.org/obo/OMIM_609266), [Orphanet:99892](http://www.orpha.net/ORDO/Orphanet_99892), [Orphanet:99893](http://www.orpha.net/ORDO/Orphanet_99893), [OMIM:202155](http://purl.obolibrary.org/obo/OMIM_202155), [OMIM:169170](http://purl.obolibrary.org/obo/OMIM_169170), [Orphanet:189427](http://www.orpha.net/ORDO/Orphanet_189427), [Orphanet:99889](http://www.orpha.net/ORDO/Orphanet_99889), [Orphanet:1359](http://www.orpha.net/ORDO/Orphanet_1359), [Orphanet:443287](http://www.orpha.net/ORDO/Orphanet_443287), [OMIM:608837](http://purl.obolibrary.org/obo/OMIM_608837), [OMIM:160980](http://purl.obolibrary.org/obo/OMIM_160980), [Orphanet:652](http://www.orpha.net/ORDO/Orphanet_652), [Orphanet:96253](http://www.orpha.net/ORDO/Orphanet_96253), [Orphanet:235936](http://www.orpha.net/ORDO/Orphanet_235936), [OMIM:240200](http://purl.obolibrary.org/obo/OMIM_240200), [OMIM:615474](http://purl.obolibrary.org/obo/OMIM_615474), [OMIM:615830](http://purl.obolibrary.org/obo/OMIM_615830), [OMIM:151623](http://purl.obolibrary.org/obo/OMIM_151623), [OMIM:615954](http://purl.obolibrary.org/obo/OMIM_615954), [Orphanet:314749](http://www.orpha.net/ORDO/Orphanet_314749), [OMIM:103230](http://purl.obolibrary.org/obo/OMIM_103230), [Orphanet:404](http://www.orpha.net/ORDO/Orphanet_404), [OMIM:605244](http://purl.obolibrary.org/obo/OMIM_605244), [Orphanet:524](http://www.orpha.net/ORDO/Orphanet_524), [Orphanet:1501](http://www.orpha.net/ORDO/Orphanet_1501), [Orphanet:403](http://www.orpha.net/ORDO/Orphanet_403), 

**Class expressions from DL-Learner:**

- [HP:0000822](http://purl.obolibrary.org/obo/HP_0000822) (Hypertension) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 52.39%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 51.37%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 51.20%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0011733](http://purl.obolibrary.org/obo/HP_0011733) (Abnormality of adrenal physiology) 50.83%
- [HP:0002717](http://purl.obolibrary.org/obo/HP_0002717) (Adrenal overactivity) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 49.35%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 49.20%
- [HP:0000822](http://purl.obolibrary.org/obo/HP_0000822) (Hypertension) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 49.10%
- [HP:0002717](http://purl.obolibrary.org/obo/HP_0002717) (Adrenal overactivity) and (not ([HP:0011767](http://purl.obolibrary.org/obo/HP_0011767) (Abnormality of the parathyroid physiology))) 48.62%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0000822](http://purl.obolibrary.org/obo/HP_0000822) (Hypertension) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 47.86%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 47.62%
- [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0011733](http://purl.obolibrary.org/obo/HP_0011733) (Abnormality of adrenal physiology) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 47.24%
- [HP:0002717](http://purl.obolibrary.org/obo/HP_0002717) (Adrenal overactivity) 47.19%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 46.10%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011732](http://purl.obolibrary.org/obo/HP_0011732) (Abnormality of adrenal morphology) 45.67%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002717](http://purl.obolibrary.org/obo/HP_0002717) (Adrenal overactivity) 45.15%


